Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase II Multicenter Trial Evaluating the Efficacy and Safety of a Systemic Hedgehog Pathway Antagonist (GDC-0449) in Patients With Basal Cell Nevus Syndrome (BCNS)

NCT00957229 is registered in ClinicalTrials.gov with UCSF Benioff Children's Hospital Oakland as lead sponsor.

NCT NCT00957229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00957229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase II Multicenter Trial Evaluating the Efficacy and Safety of a Systemic Hedgehog Pathway Antagonist (GDC-0449) in Patients With Basal Cell Nevus Syndrome (BCNS)
Lead sponsor
UCSF Benioff Children's Hospital Oakland
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2009
Completion date
January 31, 2014
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell nevus syndrome, gorlin syndrome